| known also as: |
Anti-Goat anti-PCSK9 (aa164-175) Antibody |
| known also as: |
Anti-, Caprine anti-PCSK9 (aa164-175) |
| known also as: |
Caprinae anti-PCSK9 (aa164-175) Antibody |
| known also as: |
PCSK9 |
| known also as: |
FH3, FH3, Goat Anti-PCSK9 (C Terminus), HCHOLA3, HCHOLA3, NARC-1, NARC-1, NARC1, NARC1, PCSK9, autosomal dominant 3, autosomal dominant 3, hypercholesterolemia, hypercholesterolemia, neural apoptosis regulated convertase 1, neural apoptosis regulated convertase 1, proprotein convertase subtilisin/kexin type 9, proprotein convertase subtilisin/kexin type 9, PCSK9 |
| Other names: |
NARC-1, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, convertase subtilisin/kexin type 9 preproprotein, neural apoptosis regulated convertase 1, proprotein convertase subtilisin/kexin type 9, proprotein convertase subtilisin/kexin type 9, subtilisin/kexin-like protease PC9, proprotein convertase subtilisin/kexin type 9 preproprotein |
| Gene name: |
PCSK9 |
| Other gene names: |
FH3, HCHOLA3, LDLCQ1, NARC-1, NARC-1, NARC1, NARC1, PC9, PC9, PCSK9, PCSK9 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Host organism: |
Goat |
| Species reactivity: |
Human |
| Purification method: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide |
| Form/Appearance: |
0, pH7, 02% sodium azide, 3 with 0, 5 mg/ml in Tris saline, 5% bovine serum albumin, Supplied at 0, _x000D_ |
| Concentration: |
100ug specific antibody in 200ul |
| Storage and shipping: |
Cycles of freezing and thawing should be avoided as they may damage the polypeptide chains thus reducing the activity of the antibody, After been aliquoted the antibody should be stored at -20 degrees Celsius |
| Tested for:: |
Western Blot (WB-Trf), Peptide ELISA (EIA) |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Latin name: |
Capra aegagrus hircus |
| Gene target: |
PCSK9 (aa164-175) |
| Short name: |
Goat anti-PCSK9 (aa164-175) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, goats, Antibody |
| Host: |
It are very good secondary antibodies that are affinity purified and have a good affinity themselves too, Often KLH is coupled to the antigen so anti KLH can be present in the vial, The goat polyclonal antibodies are directed against human genes or rabbit or mouse IgGs (H +L) chain primary antibodies and conjugated for detection, Goat |
| Species: |
Goats |
| Alternative name: |
caprine antibody to-proprotein convertase subtilisin/kexin classification 9 (aa164-175) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
Extracellular, PCSK9 and IDBG-99082 and ENSG00000169174 and 255738, Pcsk9 and IDBG-170186 and ENSMUSG00000044254 and 100102, this GO :0001822 and kidney development and biological process this GO :0001889 and liver development and biological process this GO :0001920 and negative regulation of receptor recycling and biological process this GO :0002092 and positive regulation of receptor internalization and biological process this GO :0004252 and serine-type endopeptidase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005764 and lysosome and cellular component this GO :0005769 and early endosome and cellular component this GO :0005770 and late endosome and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005791 and rough endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006508 and proteolysis and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006644 and phospholipid metabolic process and biological process this GO :0006915 and apoptotic process and biological process this GO :0007041 and lysosomal transport and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0009267 and cellular response to starvation and biological process this GO :0009986 and cell surface and cellular component this GO :0010469 and regulation of receptor activity and biological process this GO :0010989 and negative regulation of low-density lipoprotein particle clearance and biological process this GO :0016485 and protein processing and biological process this GO :0016540 and protein autoprocessing and biological process this GO :0019871 and sodium channel inhibitor activity and molecular function this GO :0022008 and neurogenesis and biological process this GO :0030134 and ER to this GO lgi transport vesicle and cellular component this GO :0030169 and low-density lipoprotein particle binding and molecular function this GO :0030182 and neuron differentiation and biological process this GO :0031232 and extrinsic component of external side of plasma membrane and cellular component this GO :0032799 and low-density lipoprotein receptor particle metabolic process and biological process this GO :0032802 and low-density lipoprotein particle receptor catabolic process and biological process this GO :0032803 and regulation of low-density lipoprotein particle receptor catabolic process and biological process this GO :0032869 and cellular response to insulin stimulus and biological process this GO :0034185 and apolipoprotein binding and molecular function this GO :0034189 and very-low-density lipoprotein particle binding and molecular function this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042632 and cholesterol homeostasis and biological process this GO :0043523 and regulation of neuron apoptotic process and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0043621 and protein self-association and molecular function this GO :0044822 and poly(A) RNA binding and molecular function this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050750 and low-density lipoprotein particle receptor binding and molecular function this GO :0070326 and very-low-density lipoprotein particle receptor binding and molecular function, this GO :0004252 : serine-type endopeptidase activity, this GO :0004252 : serine-type endopeptidase activity and also this GO :0005515 : protein binding and also this GO :0019871 : sodium channel inhibitor activity and also this GO :0030169 : low-density lipoprotein particle binding and also this GO :0034185 : apolipoprotein binding and also this GO :0034189 : very-low-density lipoprotein particle binding and also this GO :0034190 : apolipoprotein receptor binding and also this GO :0043621 : protein self-association and also this GO :0044822 : poly(A) RNA binding and also this GO :0050750 : low-density lipoprotein particle receptor binding and also this GO :0070326 : very-low-density lipoprotein particle receptor binding, this GO :0005515 : protein binding, this GO :0019871 : sodium channel inhibitor activity, this GO :0030169 : low-density lipoprotein particle binding, this GO :0034185 : apolipoprotein binding, this GO :0034189 : very-low-density lipoprotein particle binding, this GO :0034190 : apolipoprotein receptor binding, this GO :0043621 : protein self-association, this GO :0044822 : poly(A) RNA binding, this GO :0050750 : low-density lipoprotein particle receptor binding, this GO :0070326 : very-low-density lipoprotein particle receptor binding, very-low-density lipoprotein particle receptor binding, proprotein convertase subtilisin/kexin type 9 |
| Identity: |
20001 |
| Gene: |
PCSK9 |
More about : PCSK9 |
| Long gene name: |
proprotein convertase subtilisin/kexin type 9 |
| Synonyms gene: |
HCHOLA3 |
| Synonyms gene name: |
autosomal dominant 3 , hypercholesterolemia |
| Synonyms: |
NARC-1 FH3 |
| Locus: |
1p32, 3 |
| Discovery year: |
2003-05-13 |
| GenBank acession: |
AX207686 |
| Entrez gene record: |
255738 |
| Pubmed identfication: |
12552133 12730697 |
| RefSeq identity: |
NM_174936 |
| Classification: |
Proprotein convertase subtilisin/kexin family |
| Havana BLAST/BLAT: |
OTTHUMG00000008136 |
| Locus Specific Databases: |
British Heart Foundation LRG_275 |